Navigation Links
Tysabri Lawyers Pulaski & Middleman Launch Web Resource Center for Patients Suffering from Tysabri Side Effects
Date:8/2/2008

Houston-based Law Firm Offers Assistance, Information to People Affected by Dangerous Tysabri Effects.

Houston, TX (PRWEB) August 2, 2008 -- Tysabri side effects lawyers Pulaski & Middleman announce the launch of a http://www.tysabrilawsuitattorney.com [website] dedicated to assisting people who are suffering serious side effects as a result of taking Tysabri (natalizumab).

Tysabri, a drug used to treat multiple sclerosis (MS) and Crohn's disease, is marketed by Irish drug company Elan and US biotechnology firm Biogen Idec.

In 2005, Tysabri was briefly pulled out of the market after three patients participating in clinical trials contracted progressive multifocal leukoencephalopathy (PML), a rare but deadly viral brain infection. Although the drug was eventually re-released, two more cases of PML were reported in mid-2008, raising more concerns about Tysabri's safety and side effects.

The U.S. Food and Drug Administration (FDA) has also warned that Tysabri has the potential to cause serious liver damage leading to death or the need for a liver transplant.

As experienced litigators, http://www.tysabrilawsuitattorney.com [Tysabri lawyers] Pulaski & Middleman stand ready to assist people who have been adversely affected by this potentially dangerous drug.

About Pulaski & Middleman:
A Houston-based law firm, Pulaski & Middleman has successfully resolved thousands of cases and helped countless clients during its 15-year history. They pride themselves in a personal approach to even the most complicated cases, including medical malpractice, product liability, and other areas of personal injury law.

If you or someone you love is suffering from the side effects of Tysabri, contact Pulaski & Middlem
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Stopping Tysabri May Worsen MS
2. MS Drug Tysabri Approved for Crohns Disease
3. Tysabri May Cause Liver Damage, Health Officials Say
4. Connecticut Trial Lawyers Ask Doctors to Question Insurers Excess Profits
5. Marin County Scandal and Elder Abuse Horror: Lawsuits Link Death Nurse, Bay Area lawyers, Doctor and Blind Eye by Local, State, and National Public Officials
6. Granholm Looks To Make Big Bucks for Personal Injury Lawyers, Says Michigan Chamber of Commerce
7. Darwin Introduces Enhancements to its Lawyers Professional Liability Insurance Policy Including Privacy Wrongful Acts and More
8. The Case for Trial Lawyers
9. Get Your Fruits & Veggies: CDC
10. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
11. Story ideas from molecular & cellular proteomics
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Treatment Programs Benefit Depressed Workers 2Health News:Treatment Programs Benefit Depressed Workers 3Health News:AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year 2Health News:AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year 3Health News:AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year 4Health News:Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization 2Health News:Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization 3Health News:AHF Launches 'Public Health Division' 2Health News:AHF Launches 'Public Health Division' 3Health News:AHF Launches 'Public Health Division' 4Health News:'Making the Case:' special double issue of Critical Inquiry 2Health News:'Making the Case:' special double issue of Critical Inquiry 3Health News:Blue Cross of California and the California Governor's Council on Physical Fitness and Sports Launch 'Live Like a Champion Tour' 2Health News:Blue Cross of California and the California Governor's Council on Physical Fitness and Sports Launch 'Live Like a Champion Tour' 3
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 656 Year Old Grandmother Announces Attempt to Become First Woman to Complete the 4 Deserts 28TM 29 in Under a Year 56088 156 Year Old Grandmother Announces Attempt to Become First Woman to Complete the 4 Deserts 28TM 29 in Under a Year 56088 256 Year Old Grandmother Announces Attempt to Become First Woman to Complete the 4 Deserts 28TM 29 in Under a Year 56088 3Pelosi and Reid Invite President Obama to Address Congress 56085 1Chindex International Announces September Investor Conferences Participation 56083 1Chindex International Announces September Investor Conferences Participation 56083 2